(2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol

C25H30F3N3O2S — CID 71129748

IUPAC(2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol
SMILESCc1cc(-c2nnc([C@@](C)(N)CO)s2)ccc1OCCCCCCc1cccc(C(F)(F)F)c1
InChIInChI=1S/C25H30F3N3O2S/c1-17-14-19(22-30-31-23(34-22)24(2,29)16-32)11-12-21(17)33-13-6-4-3-5-8-18-9-7-10-20(15-18)25(26,27)28/h7,9-12,14-15,32H,3-6,8,13,16,29H2,1-2H3/t24-/m0/s1
InChIKeyFUEAUNZZPNJFBE-DEOSSOPVSA-N
MW493.60 g/mol
LogP5.88
Rot. Bonds11

About (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol

(2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol (PubChem CID 71129748) has the molecular formula C25H30F3N3O2S and a molecular weight of 493.60 g/mol. Its IUPAC name is (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol.

Molecular Properties

Compound Name(2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol
PubChem CID71129748
Molecular FormulaC25H30F3N3O2S
Molecular Weight493.60 g/mol
Exact Mass493.20
IUPAC Name(2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol
SMILESCc1cc(-c2nnc([C@@](C)(N)CO)s2)ccc1OCCCCCCc1cccc(C(F)(F)F)c1
InChIInChI=1S/C25H30F3N3O2S/c1-17-14-19(22-30-31-23(34-22)24(2,29)16-32)11-12-21(17)33-13-6-4-3-5-8-18-9-7-10-20(15-18)25(26,27)28/h7,9-12,14-15,32H,3-6,8,13,16,29H2,1-2H3/t24-/m0/s1
InChIKeyFUEAUNZZPNJFBE-DEOSSOPVSA-N
XLogP5.88
TPSA81.26 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds11
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500493.60
LogP ≤ 55.88
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol?
The IUPAC name of (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol (CID 71129748) is (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol.
What is the SMILES notation for (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol?
The canonical SMILES for (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol is Cc1cc(-c2nnc([C@@](C)(N)CO)s2)ccc1OCCCCCCc1cccc(C(F)(F)F)c1.
What is the InChIKey of (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol?
The InChIKey is FUEAUNZZPNJFBE-DEOSSOPVSA-N. The full InChI is InChI=1S/C25H30F3N3O2S/c1-17-14-19(22-30-31-23(34-22)24(2,29)16-32)11-12-21(17)33-13-6-4-3-5-8-18-9-7-10-20(15-18)25(26,27)28/h7,9-12,14-15,32H,3-6,8,13,16,29H2,1-2H3/t24-/m0/s1.
What are the key properties of (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol?
(2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol has a molecular weight of 493.60 g/mol, XLogP of 5.88, 11 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-amino-2-[5-[3-methyl-4-[6-[3-(trifluoromethyl)phenyl]hexoxy]phenyl]-1,3,4-thiadiazol-2-yl]propan-1-ol is sourced from PubChem (CID 71129748), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).